News: Rite Aid Corp (RAD.N)
3.13USD
1 Aug 2013
$0.13 (+4.33%)
$3.00
$3.04
$3.16
$3.03
3,794,934
3,251,674
$3.21
$0.95
Tue, Jul 9 2013
UPDATE 1-Lower generic drug prices hurt Jean Coutu profit
* 1st-quarter earnings C$0.51/shr vs C$1.81/share year earlier
Rite Aid posts third straight quarterly profit
- Rite Aid Corp , the No. 3 U.S. drugstore chain, posted its third consecutive quarterly profit on Thursday, helped by sales of higher-margin generic drugs.
Rite Aid forecasts current-quarter profit above estimates
- Rite Aid Corp forecast a current-quarter profit far above market estimates as the third-largest U.S. drugstore chain continued to sell more generic drugs, which carry higher profit margins.
Fitch Affirms Rite Aid's IDR at 'B-'; Outlook Stable
(The following statement was released by the rating agency) NEW YORK, April 26 (Fitch) Fitch Ratings has affirmed its ratings on Rite Aid Corporation (Rite Aid), including its Issuer Default Rating (IDR) at 'B-'. The Rating Outlook is Stable. A complete list of ratings is provided at the end of this release. KEY RATING DRIVERS: --Rite Aid's high leverage and operating statistics that significantly trail its two major competitors; --Strong market share position as the third largest U.S. drug
Canada's Jean Coutu cuts stake in Rite Aid to 11.7 pct
April 16 - Canadian drugstore chain Jean Coutu Group Inc said it has sold 72.5 million shares in Rite Aid Corp, bringing its stake in the company to 11.7 percent.
BRIEF-Rite Aid shares up 4.3 pct in premarket trading
NEW YORK, April 12 - Rite Aid Corp : * Shares up 4.3 percent in premarket trading
Rite Aid posts quarterly and annual profits, shares up
- Rite Aid Corp posted its second consecutive quarterly profit on Thursday, topping Wall Street's expectations, as the third-largest U.S. drugstore chain filled more prescriptions and sold more generic drugs, which carry higher profit margins.
UPDATE 3-Rite Aid posts quarterly and annual profits, shares up
* Shares up 20 percent to $2.14; highest level since 2009
BRIEF-Rite Aid sees spending about $65 million on prescription file purchases this year
CHICAGO, April 11 - Rite Aid Corp : * Sees spending about $65 million on prescription file purchases this year * Says would do more than $65 million in file buys if possible
BRIEF-Rite Aid shares up 10.6 pct in premarket trading
NEW YORK, April 11 - Rite Aid Corp : * Shares up 10.6 percent in premarket trading after results
- 4 Big Stocks on Traders' Radars
- Cramer's Lightning Round - Regeneron Is The Real Deal (7/31/13)
- This Executive Is Betting Millions on His Business; Should You Do the Same?
- Cramer's Lightning Round - Noble Energy Should Be Bought Aggressively (7/25/13)
- Today's Market: Investors Positioning Before Testimony, Transports And Retail Strong
- 6 Stocks Under $10 Triggering Major Breakouts
Press Releases
- Rite Aid Reports Same Store Sales for July
- Rite Aid Launches Integrated Marketing Effort to Introduce Wellness65+
- With Back-to-School Season Near, Rite Aid Offers More College & School Gear in More Stores
- Changes in Leadership, Financial Results Schedules and Monthly Sales Updates- Research Report on AmerisourceBergen, Sysco, Companhia Brasileira de Distribuicao, Rite Aid and SUPERVALU
- Pre-Market Review: Rite Aid, Walgreen, CVS Caremark, and GNC Holdings
- Rite Aid Reports Same Store Sales for June
- Rite Aid Completes Debt Refinancing Transactions
- Ken Martindale Appointed President and COO of Rite Aid
- Rite Aid Completes Debt Refinancing Transaction
- Rite Aid Reports Net Income of $89.7 Million and Adjusted EBITDA of $344.8 Million for First Quarter Fiscal 2014

